Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Zecher

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.
Nature Communications|July 22, 2018
TIGIT<sup>+</sup> iTregs elicited by human regulatory macrophages control T cell immunityPaloma Riquelme, Jan Haarer, Anja Kammler, et al.
Frontiers in Medicine|January 24, 2022
A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient RecruitmentMiriam C Banas, Georg A Böhmig, Ondrej Viklicky, et al.
HLA|April 25, 2026
Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection AssaysFalko M Heinemann, Michael Hallensleben, Karina Althaus, et al.
Transplantation Direct|August 12, 2024
Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch MethodsMalte Ziemann, Monika Lindemann, Michael Hallensleben, et al.
The New England Journal of Medicine|October 4, 2018
Fatal Encephalitic Borna Disease Virus 1 in Solid-Organ Transplant RecipientsKore Schlottau, Leonie Forth, Klemens Angstwurm, et al.
The New England Journal of Medicine|December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNFadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Frontiers in Immunology|June 25, 2026
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus reportStefan Reuter, Louise Benning, Andrea Dick, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 20, 2019
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter StudyMalte Ziemann, Wolfgang Altermann, Katharina Angert, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.
Nature Communications|July 22, 2018
TIGIT<sup>+</sup> iTregs elicited by human regulatory macrophages control T cell immunityPaloma Riquelme, Jan Haarer, Anja Kammler, et al.
Frontiers in Medicine|January 24, 2022
A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient RecruitmentMiriam C Banas, Georg A Böhmig, Ondrej Viklicky, et al.
HLA|April 25, 2026
Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection AssaysFalko M Heinemann, Michael Hallensleben, Karina Althaus, et al.
Transplantation Direct|August 12, 2024
Risk Stratification Before Living Donor Kidney Transplantation in Patients With Preformed Donor-specific Antibodies by Different Crossmatch MethodsMalte Ziemann, Monika Lindemann, Michael Hallensleben, et al.
The New England Journal of Medicine|October 4, 2018
Fatal Encephalitic Borna Disease Virus 1 in Solid-Organ Transplant RecipientsKore Schlottau, Leonie Forth, Klemens Angstwurm, et al.
The New England Journal of Medicine|December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGNFadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Frontiers in Immunology|June 25, 2026
Risk-adapted HLA delisting and imlifidase-enabled deceased-donor kidney transplantation in highly sensitized kidney transplant candidates: a German expert consensus reportStefan Reuter, Louise Benning, Andrea Dick, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 20, 2019
Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter StudyMalte Ziemann, Wolfgang Altermann, Katharina Angert, et al.
Pageof 4